Focus on urinary problems impacts effective prostate cancer diagnosis

Published: 04th August, 2022

Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a lack of scientific evidence, say experts at the University of Cambridge.

CRUK Open Lab Initiative connects cancer researchers across the UK

Published: 13th July, 2022

The Cancer Research UK Open Lab Initiative connects research groups with shared interests to spark discussion, stimulate fresh ideas and generate new collaborations.

It aims to help teams who are looking for new opportunities to exchange scientific ideas and interact more closely with other cancer research groups.

They are now expanding this established networking platform by opening it up to any research group based in the UK that is undertaking cancer-related research.

Prof Serena Nik-Zainal part of international team to receive Cancer Grand Challenge Award

Published: 16th June, 2022

Professor Serena Nik-Zainal is one of the Cambridge scientists who will receive around £4m as part of Cancer Grand Challenges, a major initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world’s leading cancer researchers to take on some of the toughest challenges in cancer research.

Serena, Group Leader at the Early Cancer Institute, is a Co-investigator in the eDyNAmiC (extrachromosomal DNA in Cancer) team, which will investigate new ways to combat treatment resistant cancers.

Funding for the Cambridge-based projects is part of an overall £80m awarded this week to four elite global teams who will deepen our understanding of cancer through international collaboration leading to new advances for people with cancer.

Cambridge researchers behind new findings which could change the way we think about DCIS in the clinic

Published: 09th June, 2022

Congratulations to Serena Nik Zainal and Helen Davies on their latest paper, out now in Nature Genetics.

Rebecca Fitzgerald receives OBE in 2022 Queen's Jubilee Birthday Honours

Published: 07th June, 2022

Many congratulations to Professor Rebecca Fitzgerald for being awarded an OBE in the 2022 Queen's Jubilee Birthday Honours List.

Artificial Intelligence aimed at detecting skin cancer is not yet ready for use in primary care

Published: 25th May, 2022

Artificial Intelligence (AI) aimed at detecting skin cancer earlier is not yet ready for use in primary care settings, due to a lack of evidence in settings where the prevalence of skin cancer is low, according to CanTest researchers.

Professor Serena Nik-Zainal elected a Fellow of the European Academy of Cancer Sciences 

Published: 16th May, 2022

Congratulations to Serena Nik-Zainal who has been elected a Fellow of the prestigious European Academy of Cancer Sciences, following nominations for the 2020-2021 election.

Cambridge early detection researcher announced as a Fellow of the Royal Society

Published: 10th May, 2022

Professor Douglas Easton is one of three CRUK Cambridge Centre members to be elected as a Fellow of the Royal Society in 2022. Doug is a Professor of Genetic Epidemiology at the University of Cambridge and a member of the Early Cancer Institute. Nine Cambridge scientists are among the new fellows, who are selected for their outstanding contributions to science.

£6.4 million for pioneering "sponge on a string" trial

Published: 28th April, 2022

Millions of pounds in funding has been announced for a trial that could pave the way for a ‘sponge on a string’ test to be established as a routine screening programme to detect Barrett’s oesophagus – a condition that can lead to oesophageal cancer.

Largest study of whole genome sequencing data reveals new clues to causes of cancer

Published: 21st April, 2022

In the largest study of its kind, a team of scientists led by Professor Serena Nik-Zainal has uncovered a 'treasure trove' of clues from their whole genome sequencing of human cancers that will allow them to detect patterns in the DNA of cancer, or ‘mutational signatures’, providing a personal history of the damage and repair processes each patient has been through.

Page 1 of 15. 147 Items Found.